Canada Neuromodulation Devices Market Insight
Published: 20 May 2026 | Report Format: Electronic (PDF)
The Canada neuromodulation devices market size is growing at a 6.84% CAGR, market arises due to the rising in Canada, boosting demand for neurostimulation, minimally invasive advanced implantable therapies
Canada Neuromodulation Devices Market Insights Forecasts to 2035
- The Canada Neuromodulation Devices Market Size Was Estimated at USD 243.1 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 6.84% from 2025 to 2035
- The Canada Neuromodulation Devices Market Size is Expected to Reach USD 471.2 Million by 2035
Notable Insights for Canada Neuromodulation Devices Market
• By product type, spinal cord stimulators constituted nearly 39-40% of market share in 2025 due to increased use in the management of chronic pain and minimally invasive neurological treatments.
• By application, chronic pain management had an approximate 34-35% market share as a result of the increased prevalence of musculoskeletal conditions, neuropathic pain, and failed back surgery syndrome in Canada.
• As per the Health Canada Medical Devices regulation, safety standards for implantable neurostimulation and neuromodulation devices have been strictly adhered to with more than CAD 250M investments in innovations and expansion of Canada’s neurology device market share.
Download the eBook (ToC)
• The Brain Canada Foundation has contributed significantly towards neurosciences research in Canada with more than CAD 200M in strategic investments, leading to advancements in neuromodulation technology and innovations within Canada’s neurological treatment device market.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Canada neuromodulation devices market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment Market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the Market.
Top Companies in Canada Neuromodulation Devices Market
• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• LivaNova PLC
• Nevro Corp.
• Integer Holdings Corporation
• NeuroPace Inc.
• Biotronik SE & Co. KG
• Synapse Biomedical Inc.
• Aleva Neurotherapeutics SA
Recent Developments:
- In October 2025, Boston Scientific expanded North America and Canada neuromodulation market, investing USD 533M acquisition of Nalu Medical, advancing WaveWriter SCS systems, enhancing chronic pain therapies and personalized neurostimulation economic growth.
- In March 2024, Brain Canada Foundation invested over CAD 250M in Canada neuroscience programs, supporting multi-institution collaborations, brain health research, and early neurotechnology innovation, strengthening national neuromodulation ecosystem and long-term medical technology economic growth.
Market Segmentation:
Canada Neuromodulation Devices Market, By Product Type
-
- Spinal Cord Stimulation Devices
- Deep Brain Stimulation Devices
- Sacral Nerve Stimulation Devices
- Vagus Nerve Stimulation Devices
- Gastric Electric Stimulation Devices
- Others
Canada Neuromodulation Devices Market, By Application
-
- Chronic Pain Management
- Parkinson’s Disease
- Epilepsy
- Depression
- Urinary & Fecal Incontinence
- Others
Canada Neuromodulation Devices Market, By End User
-
- Hospitals
- Neurology Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
Canada Neuromodulation Devices Market, By Technology
-
- Internal Neuromodulation
- External Neuromodulation
Expert Views:
The Canadian neuromodulation device market is anticipated to register robust growth in the long run on account of the rising incidence of neurological disorders, growing need for minimally invasive procedures, and technological developments within the field of neurotechnology implants. AI-driven neurostimulation, wireless implants, adaptive stimulation systems, and personalized neurological treatments are likely to revolutionize the field of neurological healthcare in the country
Author: Govind and Krishna By Spherical Insights and Consulting